Xeris Biopharma (XERS) announced that the United States Patent and Trademark Office has issued a notice of allowance for its subsidiary Xeris Pharmaceuticals’ U.S. patent application covering XP-8121, ...
About Xeris Biopharma Holdings Inc. Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has ...
1 Day XERS 2.28% DJIA -0.51% S&P Mid Cap 400 -1.30% Health Care/Life Sciences -0.36% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback